Dermira Beat Consensus Estimates
Wednesday, May 14, 2025 at 4:01 PM ET
Dermira (DERM) reported a loss of $0.18 per share on revenue of $13.14 million for the first quarter ended March 2025. The consensus estimate was a loss of $0.24 per share on revenue of $11.89 million. The company beat consensus estimates by 25.00% while revenue grew 0.84% on a year-over-year basis.
Dermira Inc is a biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-0.18
Earnings Whisper®
-
Consensus Estimate
$-0.24
Earnings Surprise
Earnings Growth
Reported Revenue
$13.14 Mil
Revenue Estimate
$11.89 Mil
Revenue Surprise
Revenue Growth